Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized StudyClin. Cancer Res 2022 Aug 15;28(16)3433-3442, M Cristofanilli, HS Rugo, SA Im, DJ Slamon, N Harbeck, I Bondarenko, N Masuda, M Colleoni, A DeMichele, S Loi, H Iwata, B O'Leary, F André, S Loibl, E Bananis, Y Liu, X Huang, S Kim, MJ Lechuga Frean, NC Turner
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.